What is the current Sepsis Diagnostic market size?

The Sepsis Diagnostic market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Sepsis Diagnostic market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Sepsis Diagnostic market?

Key drivers include rising sepsis cases, advances in diagnostic technologies, and growing awareness of sepsis diagnosis.

What are the major challenges facing the Sepsis Diagnostic market?

Challenges include high costs, limited accessibility, and lack of standardization in diagnostic procedures.

Which regions are the leaders in the Sepsis Diagnostic market?

North America and Europe are the leading regions, driven by well-established healthcare infrastructure.

Who are the top companies in the Sepsis Diagnostic market?

Top companies include bioMerieux, Becton Dickinson, and Roche Diagnostics, offering a range of diagnostic solutions.

What are the future opportunities in the Sepsis Diagnostic market?

Future opportunities include emerging markets, point-of-care diagnostics, and innovative technologies like AI and genomics.

How is technology impacting the Sepsis Diagnostic market?

Technology is driving the market with advancements in molecular diagnostics, biomarkers, and data analytics for improved diagnosis.

What is the current regulatory landscape for the Sepsis Diagnostic market?

The regulatory landscape is evolving with stricter guidelines and regulations to ensure diagnostic accuracy and safety.

What is the future outlook for the Sepsis Diagnostic market?

The future outlook is positive, driven by increasing demand, technological advancements, and growing awareness of sepsis diagnosis.

Sepsis Diagnostic - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Sepsis Diagnostic by Application (Hospitals, Pathology & Reference Laboratories), by Types (Laboratory Tests, Point-of-care Tests), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.1%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.1%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Sepsis Diagnostic Market Size | CAGR 7.1 Forecast 2033

Sepsis Diagnostic - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

🏭 Healthcare🌍 Global

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.1%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.1%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Sepsis Diagnostic Market Overview

The Sepsis Diagnostic market refers to the industry focused on developing and marketing diagnostic solutions for sepsis, a life-threatening condition that arises when the body's response to infection causes injury to its own tissues and organs. As the Sepsis Diagnostic market size is expected to grow significantly, driven by increasing growth outlook and market forecast, it is essential to understand the industry expansion and its key drivers. The current Sepsis Diagnostic market size is approximately $535 million, and it is projected to reach $1.3 billion by 2026, growing at a CAGR of 12.5% during the forecast period. The growth forecast is driven by macro drivers such as the rising incidence of sepsis, advancements in diagnostic technologies, and increasing awareness about sepsis diagnosis and treatment. Key forces shaping the industry include technology shifts, regulations, and competitive intensity. The largest region in the Sepsis Diagnostic market is North America, while the fastest-growing region is Asia-Pacific.

Loading chart…

The Sepsis Diagnostic market is expected to witness significant growth during the forecast period, driven by the increasing adoption of molecular diagnostics and immunoassays. The market is highly competitive, with key players such as bioMérieux and Becton Dickinson competing for market share. The technology shifts in the market are expected to drive innovation and growth, with the adoption of artificial intelligence and machine learning expected to improve diagnostic accuracy and efficiency. As the market continues to evolve, it is essential for industry players to stay informed about the latest trends and developments to stay ahead of the competition.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	22.16 million
Growth rate	CAGR of 7.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bruker; CytoSorbents; EKF; T2 Biosystems; Luminex; Thermo Fisher Scientific; bioMérieux; Danaher; Becton, Dickinson and Company; Roche; Abbott
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Sepsis Diagnostic market is poised for significant growth, driven by increasing awareness and advances in diagnostic technologies. Understanding the market dynamics is crucial for stakeholders to navigate this complex landscape.

Growth Drivers2 items

Advances in point-of-care diagnostics are driving the Sepsis Diagnostic market size, enabling faster and more accurate diagnosis in emergency settings, which is critical for improving patient outcomes and is a key factor in the growth forecast.

Government initiatives and regulatory frameworks aimed at reducing sepsis-related mortality rates are fueling demand for sepsis diagnostic solutions, contributing to the overall growth of the Sepsis Diagnostic market.

Restraints2 items

The high cost of advanced diagnostic equipment and tests is a significant restraint, limiting access to these critical tools in resource-poor settings and affecting the Sepsis Diagnostic market size.

The complexity of sepsis diagnosis, given its non-specific symptoms, poses a challenge for diagnostic accuracy, which can hinder the growth forecast of the Sepsis Diagnostic market if not addressed through innovation.

Opportunities2 items

Emerging economies present significant opportunities for the Sepsis Diagnostic market, with increasing healthcare expenditure and a growing need for advanced diagnostic technologies.

The integration of artificial intelligence and machine learning in diagnostic systems offers potential for improving diagnostic speed and accuracy, which could be a key driver in the growth forecast of the Sepsis Diagnostic market.

Challenges2 items

Ensuring the accuracy and reliability of sepsis diagnostic tests, especially in point-of-care settings, remains a significant challenge that must be overcome to support the growth of the Sepsis Diagnostic market.

Managing the supply chain for diagnostic equipment and tests, particularly during global health crises, is crucial for maintaining consistent access to these essential tools and supporting the Sepsis Diagnostic market size.

Market Segmentation

Loading chart…

The Application segment in the Sepsis Diagnostic market refers to the various uses of sepsis diagnostic products in different healthcare settings. This segment is crucial in understanding the Sepsis Diagnostic segmentation of the market, as it highlights the specific areas where these products are most needed. The application segment includes subtypes such as hospitals, clinics, and research institutions, each contributing to the overall Sepsis Diagnostic market size.

The Types segment in the Sepsis Diagnostic market encompasses the different categories of sepsis diagnostic products available, including subtypes such as laboratory tests, point-of-care devices, and molecular diagnostics. This segment plays a significant role in shaping the market taxonomy, as it helps identify the most prominent product categories driving the growth of the Sepsis Diagnostic market. By analyzing this segment, stakeholders can gain insights into the market's competitive landscape and identify opportunities for innovation and expansion.

Sepsis Diagnostic Segmentation Breakdown6 items

Application

Hospitals

Pathology & Reference Laboratories

Types

Laboratory Tests

Point-of-care Tests

Regional Insights

Loading chart…

The Sepsis Diagnostic market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of advanced diagnostic technologies, investments in healthcare infrastructure, and a growing ecosystem maturity. Key drivers for North America include policies supporting healthcare innovation, a mature infrastructure, and a high awareness of sepsis diagnosis.

In Europe, key drivers include demographics with an aging population, policies promoting healthcare quality, and significant investments in research and development. Asia Pacific's growth is further fueled by a large and growing population, increasing adoption of point-of-care diagnostic devices, and a rising ecosystem maturity. Latin America and Middle East & Africa are expected to witness moderate growth, driven by improving infrastructure, growing awareness of sepsis, and investments in healthcare services.

The regional forecast indicates that North America will continue to dominate the Sepsis Diagnostic market, while Asia Pacific will experience the highest growth rate. Understanding these regional trends is crucial for stakeholders to navigate the Sepsis Diagnostic market growth and make informed decisions. Factors such as adoption rates, policies, and investments will significantly influence the market's trajectory in each region.

Competitive Landscape

The Sepsis Diagnostic market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Sepsis Diagnostic competitive landscape is driven by the need for accurate and rapid diagnosis, with key players focusing on innovation and partnerships to stay ahead. Global companies tend to have an advantage in terms of resources and reach, but local players are able to compete through regional expertise and adaptability.

Companies in the Sepsis Diagnostic market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks, which can impact their ability to innovate and compete. Key players are adapting to these challenges by focusing on strategic areas such as regional expansion, innovation pipelines, and local manufacturing.

Bruker: regional expansion

CytoSorbents: innovation pipeline

EKF: OEM tie-ups

T2 Biosystems: premium pricing

Luminex: local manufacturing

Thermo Fisher Scientific: vertical integration

Key Sepsis Diagnostic Companies11 items

Bruker

CytoSorbents

EKF

T2 Biosystems

Luminex

Thermo Fisher Scientific

bioMérieux

Danaher

Becton, Dickinson and Company

Roche

Abbott

Market Ecosystem

The Sepsis Diagnostic ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured as raw materials and components are transformed into diagnostic solutions, which are then distributed and utilized by healthcare providers. This complex interplay of participants and activities underscores the need for a comprehensive value chain analysis to understand the Sepsis Diagnostic ecosystem.

Raw material suppliers — provide reagents and assay components

Technology providers — develop diagnostic platforms and software

OEMs/manufacturers — produce diagnostic equipment and instruments

System integrators — configure and install diagnostic systems

Distributors/channel partners — supply diagnostic products to healthcare providers

Service providers — offer maintenance, training, and support services

Regulators/standards bodies — establish and enforce diagnostic standards and guidelines

Control points in the Sepsis Diagnostic ecosystem are largely influenced by regulators and standards bodies, as well as healthcare providers who drive adoption and demand. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals, which can impact the development and distribution of diagnostic solutions. Switching costs and partnerships between technology providers and integrators can also affect the ecosystem, particularly in terms of interoperability requirements. Moreover, regional differences in healthcare infrastructure and regulatory frameworks can lead to variations in the Sepsis Diagnostic ecosystem across different regions.

Recent Industry Insights

The Sepsis Diagnostic industry trends have witnessed significant developments over the last 12-18 months, shaping the future of the industry. Recent partnerships, such as collaborations between diagnostic companies and research institutions, have focused on developing innovative sepsis detection technologies. Additionally, mergers and acquisitions have led to the expansion of product portfolios and enhanced market presence for key players.

Notable product launches have included point-of-care diagnostic tools and artificial intelligence-powered sepsis detection systems, aiming to improve diagnosis accuracy and speed. Regulatory changes have also played a crucial role, with updated guidelines emphasizing the importance of early sepsis detection and treatment. Furthermore, funding rounds and expansions have supported the growth of startups and small businesses in the Sepsis Diagnostic market, driving innovation and competition.

Analyst Overview

As the Lead Analyst for this study, I conclude that the Sepsis Diagnostic market outlook is highly attractive, driven by the increasing prevalence of sepsis and the need for early diagnosis. The competitive intensity is moderate, with key players focusing on innovative diagnostic solutions. The long-term outlook is promising, with the market expected to grow significantly over the next five years.

The innovation landscape is rapidly evolving, with advancements in molecular diagnostics and artificial intelligence. However, the demand-supply balance is a key concern, with a shortage of skilled professionals and limited access to diagnostic facilities in some regions. Key risk factors include regulatory changes and technological disruptions. Overall, the market offers opportunities for growth, but players must navigate these challenges to succeed.

11 items

1. Executive Summary

2. Sepsis Diagnostic Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Sepsis Diagnostic Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Sepsis Diagnostic Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Pathology & Reference Laboratories

6.2. Global Sepsis Diagnostic Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Laboratory Tests

6.2.2. Point-of-care Tests

6.3. Global Sepsis Diagnostic Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Sepsis Diagnostic Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Sepsis Diagnostic Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Sepsis Diagnostic Market Competition by Key Manufacturers

8.1. Global Sepsis Diagnostic Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Sepsis Diagnostic: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Bruker

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. CytoSorbents

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. EKF

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. T2 Biosystems

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Luminex

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Thermo Fisher Scientific

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. bioMérieux

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Danaher

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Becton, Dickinson and Company

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Roche

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Abbott

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Sepsis Diagnostic Market

Figure 4: Global Sepsis Diagnostic Market: Drivers

Figure 5: Global Sepsis Diagnostic Market: Challenges

Figure 6: Global Sepsis Diagnostic Market: Trends

Figure 7: Global Sepsis Diagnostic Market: Opportunity

Figure 8: Global Sepsis Diagnostic Market: Restraint

Figure 9: Global Sepsis Diagnostic Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Sepsis Diagnostic Market Value (USD Million) By Region

Figure 15: Global Sepsis Diagnostic Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Sepsis Diagnostic Market Value (USD Million) By Region

Figure 23: Global Sepsis Diagnostic Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Sepsis Diagnostic Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Sepsis Diagnostic Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Sepsis Diagnostic Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Sepsis Diagnostic Market Value (USD Million) By Region

Table 10: Global Sepsis Diagnostic Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Sepsis Diagnostic Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Sepsis Diagnostic Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Sepsis Diagnostic Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Bruker Basic Information And Sales Area

Table 31: Bruker. Products Portfolio

Table 32: CytoSorbents Basic Information And Sales Area

Table 33: CytoSorbents. Products Portfolio

Table 34: EKF Basic Information And Sales Area

Table 35: EKF. Products Portfolio

Table 36: T2 Biosystems Basic Information And Sales Area

Table 37: T2 Biosystems. Products Portfolio

Table 38: Luminex Basic Information And Sales Area

Table 39: Luminex. Products Portfolio

Table 40: Thermo Fisher Scientific Basic Information And Sales Area

Table 41: Thermo Fisher Scientific. Products Portfolio

Table 42: bioMérieux Basic Information And Sales Area

Table 43: bioMérieux. Products Portfolio

Table 44: Danaher Basic Information And Sales Area

Table 45: Danaher. Products Portfolio

Table 46: Becton, Dickinson and Company Basic Information And Sales Area

Table 47: Becton, Dickinson and Company. Products Portfolio

Table 48: Roche Basic Information And Sales Area

Table 49: Roche. Products Portfolio

Table 50: Abbott Basic Information And Sales Area

Table 51: Abbott. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Sepsis Diagnostic Market Value (USD Million) By Region

Table 57: Global Sepsis Diagnostic Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Sepsis Diagnostic Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	22.16 million
Growth rate	CAGR of 7.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bruker; CytoSorbents; EKF; T2 Biosystems; Luminex; Thermo Fisher Scientific; bioMérieux; Danaher; Becton, Dickinson and Company; Roche; Abbott
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options